· 6/6/2014
City of Edinburgh Council as A v. Pfizer Inc
Citations
- 754 F.3d 159
- 2014 WL 2535383
- 2014 U.S. App. LEXIS 10550
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- holding that, because plaintiffs “failed to adequately plead a predicate section 10(b) violation, their section 20(a) claim must be dismissed”
- holding that “[i]nterpretations of clinical trial data are considered opinions . . . only 25 actionable under the securities laws if they are not honestly believed and lack a reasonable basis.”
- suggesting that a company's failure to accurately disclose clinical data may be actionable where it made affirmative false statements about a drug's safety
- indicating that a company's failure to accurately disclose clinical trial data may be actionable, but suggesting no duty to disclose where there were no affirmative statements about its Phase 2 study results
- holding at the motion to dismiss stage that the adjective “spectacular” was a 6 Case: 19-20298 Document: 00515532811 Page: 7 Date Filed: 08/19/2020 No. 19-20298 vague and general statement of optimism that was not misleading
- explaining that the PSLRA imposes “heightened pleading standards” in securities fraud actions
Source: CourtListener parenthetical corpus (CC0).
Judges: Smith, Shwartz, Scirica
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.